EMG
ALXN

ETF Managers Group’s Alexion Pharmaceuticals ALXN Stock Holding History

ETF Managers Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,048
Closed -$377K – 739
2021
Q2 		$377K Sell
2,048
-389
-16% -$66.8K 0.01% 569
2021
Q1 		$374K Sell
2,437
-660
-21% -$102K 0.01% 559
2020
Q4 		$484K Sell
3,097
-197
-6% -$25.3K 0.01% 360
2020
Q3 		$370K Buy
+3,294
New +$355K 0.01% 378
2019
Q3 		– Sell
-3,204
Closed -$404K – 590
2019
Q2 		$404K Sell
3,204
-10,448
-77% -$1.35M 0.01% 263
2019
Q1 		$1.84M Sell
13,652
-3,917
-22% -$487K 0.09% 110
2018
Q4 		$1.71M Sell
17,569
-2,485
-12% -$294K 0.08% 136
2018
Q3 		$2.79M Buy
+20,054
New +$2.52M 0.11% 102
2016
Q1 		$22K Buy
+181
New +$26.6K 0.02% 449

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return